Using a similar approach, fluorescent RON-deficient and proficient cells were injected into a ZF line with red fluorescently tracked endothelium: RON deficiency reduced local tumor burden at injection sites and perivascular areas with metastatic cells [172]. The gene discussed is MST1R; the disease is neoplasm.